封面
市場調查報告書
商品編碼
1197854

骨科指間植入物市場——增長、趨勢、COVID-19 影響和預測 (2023-2028)

Orthopedic Digit Implants Market - Growth, Trends, and Forecasts (2023 - 2028)

出版日期: | 出版商: Mordor Intelligence | 英文 115 Pages | 商品交期: 2-3個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

在 2022 年至 2027 年的預測期內,骨科指間植入物市場預計將以 7% 的複合年增長率增長。

COVID-19 疫情對市場產生了重大影響。 聯邦基金估計,COVID-19 將使 2020 年 5 月的首次就診次數減少 60%。 預計這會削弱通常在門診進行的骨科治療的需要。 由於世界各國政府施加的社會動盪,醫院和醫療服務嚴重減少,COVID-19 的爆發正在影響市場。 COVID-19 流行病也影響了全球經濟,對世界各地醫院中非 COVID-19 患者的標準醫院護理實踐產生了重大影響。 由於許多醫院和診所因設施關閉而關閉,短期內對數字骨植入物的需求將會減少。 根據英國外科雜誌發表的一項研究,2020 年 5 月,由於 COVID-19 導致主要醫院服務中斷 12 週或本應推遲,到 2020 年全球約有 2840 萬次擇期手術被取消。 根據國際組織 2020 年 5 月的一項研究,由於 COVID-19 流行病,印度有超過 580,000 例組織手術被取消或推遲。 這些不存在的服務的推遲減少了對數字骨植入物的需求。 然而,在 COVID-19 流行之後,隨著召回服務的處理,對這種數字輸入的需求將會增加。

不斷增長的全球老年人口和不斷上升的關節炎是數字人工授精市場的主要支柱。 此外,對微創技術的認識不斷提高以及 3D 打印技術的出現徹底改變了骨科技術的使用。 預計這將對預測期內的市場增長產生積極影響。 根據文章《骨關節炎:根據 2021 年 2 月發表的“你需要知道的”》,到 2050 年,60 歲以上的人將佔世界人口的 20% 以上,這是一個變態。這意味著生殖器關節炎患者人數將達到1.3億。 關節炎患病率的上升和關節炎症狀負擔的增加預計將推動市場增長。

同樣,根據聯合國經濟和社會事務部發布的《2020年人口老齡化亮點》報告,到2050年,全球將有15億人超過65歲。 隨著全球人口老齡化,患有骨質疏鬆症的人數可能會增加。 隨著年齡的增長,我們的骨骼變得脆弱,更容易骨折。 因此,上述所有統計數據都表明世界人口正在快速增長,這將推動未來的市場增長。

此外,向市場推出新產品也將促進所研究市場的增長。 例如,2021 年 8 月,骨科植入物公司推出了一種名為 DRPx 系統的腕部骨折電鍍技術,該技術具有增強的人體工程學設計,以滿足骨科醫生的手術偏好。

然而,有限的醫療保險引入和嚴格的監管政策預計將阻礙預測期內的市場增長。

骨科指間植入物的市場趨勢

預計在預測期內,蹠骨關節植入部分將佔很大份額

由於關節炎的增加和全球風險的增加,預計蹠骨合成植物將佔據很大的市場份額。 治療損傷最常見的手術之一是蹠趾關節 (MTP) 植入的第一步。 在這項手術中,一個小型的兩件式植入物覆蓋了 MTP 關節中受損或缺失的關節軟骨,大腳趾的球與腳相遇。 這種植入物可以恢復關節的活動能力,並允許關節之間相對平穩地移動。 該手術通常用於治療大而僵硬的腳趾。

根據世界衛生組織 (WHO) 於 2021 年 6 月更新的數據,估計每年有 135 萬人死於道路交通事故。 每年大約有 20 至 5000 萬人在道路交通事故中受傷或致殘。 這些新興市場的發展預計將在預測期內對市場增長做出重大貢獻。

此外,該細分市場新產品的推出有望在研究期間進一步推動市場增長。 例如,2021 年 2 月,Accufix Surgical 獲得了美國食品和藥物管理局 (FDA) 的批准,可以部署 AccuJoint 計劃,這是一種在不降低堅固或脆弱骨骼的情況下恢復 MTP 功能和運動的新方法。我得到了 這是一種失重裝置,足部外科醫生可以為患者選擇關節維護而不是關節整合。

此外,產品技術的進步和全球骨質疏鬆症負擔的加重預計將對整個市場的增長產生積極影響。

預計在預測期內北美將顯著增長

預計北美地區在預測期內將出現顯著的市場增長。 這種增長的背後是骨質疏鬆症的高患病率、老年人口的增加以及不干擾治療的外科手術的普及。 此外,更多市場參與者的出現和新產品的推出正在推動該地區的市場增長。

預計不斷增長的老年人口將推動這一細分市場的增長。 例如,加拿大統計局2021年9月的數據顯示,老年人口逐年增加。 它還報告說,2020 年 65 歲及以上人口占近 6,845,502 人,到 2021 年達到 7,081,792 人。 預計易患骨折和其他慢性病的人口老齡化將推動市場增長。

此外,該地區骨科數字化的引入有望進一步推動市場增長。 例如,2020 年 12 月,Ensemble Orthopedics Inc. 獲得了美國食品和藥物管理局的 510(k) 批准,可以安裝 Ensemble CMC。 Ensemble CMC 旨在通過微創小手術治療前腕踝關節 (CMC) 骨關節炎患者。

因此,由於上述原因,預計學習市場將在預測期內增長。

骨科指間植入物市場競爭者分析

骨科指間植入物市場相對分散,只有幾家主要市場參與者。 市場參與者正專注於地域擴張、新產品發布和新產品開發。 主要市場參與者包括強生公司(DePuy Synthes)、施樂輝、史賽克公司、Integra LifeSciences、Accumed LLC 等。

其他好處

  • Excel 格式的市場預測 (ME) 表
  • 三個月的分析師支持

內容

第1章介紹

  • 研究假設和市場定義
  • 調查範圍

第2章研究方法論

第 3 章執行摘要

第4章市場動態

  • 市場概覽
  • 市場驅動因素
    • 老齡化人口的增加和骨科疾病患病率的增加
    • 對微創手術和先進產品的偏好不斷上升
  • 市場製約因素
    • 嚴格的監管程序
    • 術後感染和種植體適應性低
  • 波特的五力分析
    • 新進入者的威脅
    • 買方/消費者議價能力
    • 供應商的議價能力
    • 替代品的威脅
    • 競爭公司之間的敵對關係

第 5 章市場細分(基於價值的市場規模 - 百萬美元)

  • 按產品類型
    • 跗管植入物
    • 腕骨植入物
    • 腳趾髓內植入物
    • 舟骨植入物
    • 新月骨植入物
  • 按材料
    • 熱解碳
    • 鎳鈦諾
    • 其他材料
  • 最終用戶
    • 醫院
    • 骨科診所
  • 按地區
    • 北美
      • 美國
      • 加拿大
      • 墨西哥
    • 歐洲
      • 德國
      • 英國
      • 法國
      • 意大利
      • 西班牙
      • 其他歐洲地區
    • 亞太地區
      • 中國
      • 日本
      • 印度
      • 澳大利亞
      • 韓國
      • 其他亞太地區
    • 中東
      • 海灣合作委員會
      • 南非
      • 其他中東地區
    • 南美洲
      • 巴西
      • 阿根廷
      • 其他南美洲

第6章競爭格局

  • 公司簡介
    • Smith & Nephew
    • Johnson & Johnson
    • Stryker Corporation
    • Arthrex GmbH
    • Vilex In Tennessee Inc.
    • Merete GmbH
    • Acumed LLC
    • Teijin Limited
    • Arthrosurface
    • Advin Health Care
    • Bond Well Ortho Products
    • Zimmer Biomet

第7章 市場機會與今後動向

簡介目錄
Product Code: 67820

The orthopedic digit implants market is expected to register a CAGR of 7% over the forecast period, 2022-2027.

The COVID-19 epidemic has had a profound effect on the market. According to the Commonwealth Fund, it is estimated that there will be a 60% reduction in the initial outpatient visits in May 2020 due to COVID-19. This was expected to hurt the need for orthopedic sessions as is usually done in outpatient departments. The outbreak of COVID-19 has had an impact on the market, as hospital and health care services have been severely curtailed due to social unrest taken by governments around the world. In addition, the COVID-19 epidemic has affected the global economy and has shown a significant impact on the performance of standard hospital care for non-COVID-19 patients in hospitals around the world. As many hospitals and clinics remain closed due to the closure of facilities, the need for digital bone implants decreases in the short term. According to a study published in the British Journal of Surgery, in May 2020, based on 12 weeks of major hospital services disruption due to COVID-19, approximately 28.4 million elective surgeries worldwide will be canceled or postponed by 2020. More than 580,000 organized surgery in India was canceled or delayed due to the COVID-19 epidemic, according to a study by the international organization in May 2020. With the postponement of these non-existent services, the need for a digital bone implant has fallen. However, after the COVID-19 epidemic, the collected services will be handled, which increases the need for this digital input.

The increasing geriatric population worldwide and the rise of arthritis are the mainstays of the digital artificial insemination market. In addition, growing awareness about less intrusive technology and the advent of 3D printing technology has revolutionized the use of orthopedic technology. This is expected to have a positive impact on market growth in the forecast period. According to the article "Osteoarthritis: What You Need to Know" published in February 2021, people over the age of 60 will account for more than 20% of the world's population by 2050 which means the number of osteoarthritis sufferers will reach 130 million. The growing prevalence of arthritis and the increasing burden of arthritis conditions are expected to boost market growth.

Similarly, according to a report by the United Nations Department of Economics and Social Affairs, 2020 Highlights on Population Ageing, by 2050, globally, 1.5 billion people are living aged 65 years or over. With the growing number of elderly people worldwide, there may be an increase in the number of people suffering from osteoporosis. As a person grows older, his bones become weaker, which makes him more prone to fractures. Thus, all of the above statistics indicate that the world's population is growing rapidly, encouraging future market growth.

Additionally, the launch of new products in the market will also boost the studied market growth. For instance, in August 2021, the Orthopedic Implant Company launched wrist fracture plating technology, called the DRPx System with an enhanced ergonomic design to meet the technique preferences of orthopedic surgeons.

However, the introduction of limited medical insurance and strict regulatory policies are expected to hamper market growth over the forecast period.

Orthopedic Digit Implants Market Trends

The Meta Tarsal Joint Implants Segment is Expected to Hold a Significant Share Over the Forecast Period

Metatarsal integrated plants are expected to have a significant market share due to the increase in arthritis and the growing number of risks worldwide. One of the most common procedures for treating injuries is the first step in the metatarsal-phalangeal joint (MTP) transplant procedure. This procedure involves a small, two-piece implant to cover the damaged or missing articular cartilage in the MTP joint, where the base of the big toe meets the foot. The implant can restore mobility to the joints and allow them to move smoothly against one another. This procedure is often used to treat large hard toes.

According to the World Health Organization update in June 2021, an estimated 1.35 million people die as a result of road accidents each year. In addition, some 20 to 50 million people are injured or disabled each year as a result of road accidents. These developments are expected to make a significant contribution to market growth in the forecast period.

In addition, the introduction of new products in the segment is expected to further market growth during the study period. For example, in February 2021, Accufix Surgical received approval from the United States Food and Drug Administration (FDA) to roll out its Accu-Joint program, a new method of fully restoring MTP function and movement that does not degrade solid or weak bone. This is a weightless plant that allows surgeon foot surgeons to opt for joint maintenance over the joint integration of their patients.

In addition, advances in product technology and the increasing burden of osteoporosis worldwide are expected to have a positive impact on overall market growth.

North America Projected to Grow at Significant Rate Over the Forecasted Period

The North American region is expected to have significant market growth during the forecast period. Growth is due to the high prevalence of osteoporosis, an increase in the number of elderly people, and the increasing popularity of surgical procedures that do not interfere with treatment. In addition, the presence of more market players and the introduction of new products encourages market growth in the region.

The growing elderly population is expected to drive the growth of the market segment. For Instance, Statistics Canada. September 2021 data, the geriatric population is growing year on year. It also reported that in 2020, the population aged 65 years or over accounts for nearly 6,845,502 and it reached 7,081,792 in 2021. Such an increasing geriatric population which is more prone to fractures and other chronic diseases is expected to drive the growth of the market.

In addition, the introduction of digital orthopedic digitalization in the region is expected to further boost market growth. For example, in December 2020, Ensemble Orthopedics Inc. received 510 (k) approval from the United States Food and Drug Administration for its inclusion of the Ensemble CMC. Ensemble CMC is designed to treat patients with osteoarthritis of the anterior segment of the carpometacarpal joint (CMC) using a minimally invasive, simple surgical procedure.

Therefore, as a result of the above, the market learned is expected to grow during the forecast period.

Orthopedic Digit Implants Market Competitor Analysis

The Orthopedic Digit Implants market is moderately fragmented, with a few major market players. Market players are focusing on geographic expansions, new product launches, and the development of new products. The key market players include Johnson & Johnson (DePuy Synthes), Smith & Nephew, Stryker Corporation, Integra Lifesciences, and Acumed LLC.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Geriatric Population and Rising Prevalence of Orthopedic Diseases
    • 4.2.2 Increasing Preference of Minimally Invasive Surgeries and Advanced Products
  • 4.3 Market Restraints
    • 4.3.1 Stringent Regulatory Procedures
    • 4.3.2 Post Surgery Infections and low Adaptation of Implants
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD Million)

  • 5.1 By Product Type
    • 5.1.1 Meta Tarsal Joint Implants
    • 5.1.2 Meta Carpal Joint Implants
    • 5.1.3 Toe Intramedullary Digit Implants
    • 5.1.4 Scophoid Bone Digit Implants
    • 5.1.5 Hemiphalangeal Digit Implants
  • 5.2 By Material
    • 5.2.1 Pyrocarbon
    • 5.2.2 Titanium
    • 5.2.3 Nitinol
    • 5.2.4 Other Materials
  • 5.3 By End User
    • 5.3.1 Hospitals
    • 5.3.2 Speciality Orthopedic Clinics
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle East
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle East
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Smith & Nephew
    • 6.1.2 Johnson & Johnson
    • 6.1.3 Stryker Corporation
    • 6.1.4 Arthrex GmbH
    • 6.1.5 Vilex In Tennessee Inc.
    • 6.1.6 Merete GmbH
    • 6.1.7 Acumed LLC
    • 6.1.8 Teijin Limited
    • 6.1.9 Arthrosurface
    • 6.1.10 Advin Health Care
    • 6.1.11 Bond Well Ortho Products
    • 6.1.12 Zimmer Biomet

7 MARKET OPPORTUNITIES AND FUTURE TRENDS